🇺🇸 Kalinox in United States

76 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 76

Most-reported reactions

1. Encephalopathy — 18 reports (23.68%)
2. Condition Aggravated — 8 reports (10.53%)
3. Lymphopenia — 8 reports (10.53%)
4. Anaemia Vitamin B12 Deficiency — 7 reports (9.21%)
5. Confusional State — 7 reports (9.21%)
6. Renal Failure Acute — 7 reports (9.21%)
7. Subacute Combined Cord Degeneration — 7 reports (9.21%)
8. Polyneuropathy — 6 reports (7.89%)
9. Drug Use Disorder — 4 reports (5.26%)
10. Haematuria — 4 reports (5.26%)

Source database →

Frequently asked questions

Is Kalinox approved in United States?

Kalinox does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Kalinox in United States?

Weprom is the originator. The local marketing authorisation holder may differ — check the official source linked above.